The Rheumatological disease process : focus on piroxicam

LDR 01712nam a22003851a 4500
001 000660743
003 MiAaHDL
005 20241229000000.0
006 m d
007 cr bn ---auaua
008 880719s1985 enka b 100 0 eng
010 ⊔ ⊔ ‡a 84007176
020 ⊔ ⊔ ‡a0199220050 ‡q(Oxford University Press) ‡c$13.95 (U.S.)
035 ⊔ ⊔ ‡a(MiU)990006607430106381
035 ⊔ ⊔ ‡asdr-miu.990006607430106381
035 ⊔ ⊔ ‡z(MiU)MIU01000000000000000660743-goog
035 ⊔ ⊔ ‡a(OCoLC)59190923
035 ⊔ ⊔ ‡a(CaOTULAS)160648770
035 ⊔ ⊔ ‡a(RLIN)MIUG86-B39003
035 ⊔ ⊔ ‡z(MiU)Aleph000660743
040 ⊔ ⊔ ‡dCStRLIN ‡dOkU ‡dMiU ‡dUtOrBLW
050 0 4 ‡aRC927 ‡b.R476 1983
060 ⊔ 4 ‡aW3 IN207 no. 67 ‡aWE 344 R4717 1983
082 0 ⊔ ‡a616.7/23/061 ‡219
245 0 4 ‡aThe Rheumatological disease process : ‡bfocus on piroxicam / ‡cedited by R.G. Richardson.
260 ⊔ ⊔ ‡aLondon : ‡bRoyal Society of Medicine ; ‡aOxford ; ‡aNew York : ‡bOxford University Press, ‡c1985.
300 ⊔ ⊔ ‡ax, 104 p. : ‡bill. ; ‡c24 cm.
336 ⊔ ⊔ ‡atext ‡btxt ‡2rdacontent
337 ⊔ ⊔ ‡aunmediated ‡bn ‡2rdamedia
338 ⊔ ⊔ ‡avolume ‡bnc ‡2rdacarrier
490 0 ⊔ ‡aInternational congress and symposium series ; ‡vno. 67
500 ⊔ ⊔ ‡aProceedings of an international symposium held in London, April 29, 1983, and sponsored by Pfizer International.
538 ⊔ ⊔ ‡aMode of access: Internet.
650 ⊔ 0 ‡aPiroxicam ‡xTesting ‡vCongresses.
650 ⊔ 0 ‡aRheumatism ‡xChemotherapy ‡vCongresses.
700 1 ⊔ ‡aRichardson, Robert G.
710 2 ⊔ ‡aPfizer International. ‡0http://id.loc.gov/authorities/names/n78015676 ‡1http://id.loc.gov/rwo/agents/n78015676
899 ⊔ ⊔ ‡a39015009572994
CID ⊔ ⊔ ‡a000660743
DAT 0 ⊔ ‡a20241217200128.0 ‡b20241229000000.0
DAT 1 ⊔ ‡a20250103184744.0 ‡b2025-01-04T13:23:43Z
DAT 2 ⊔ ‡a2024-02-28T18:30:02Z
CAT ⊔ ⊔ ‡aSDR-MIU ‡cmiu ‡dALMA ‡lprepare.pl-004-009
FMT ⊔ ⊔ ‡aBK
HOL ⊔ ⊔ ‡0sdr-miu.990006607430106381 ‡aMiU ‡bSDR ‡cMIU ‡f000660743 ‡pmdp.39015009572994 ‡sMIU ‡1990006607430106381
974 ⊔ ⊔ ‡bMIU ‡cMIU ‡d20250104 ‡sgoogle ‡umdp.39015009572994 ‡y1985 ‡ric ‡qbib ‡tnon-US bib date1 >= 1930